Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/7/15 → 4/7/18 |
Funding
- Clinipace, Inc. (Prot #KCP-330-006 // Prot #KCP-330-006)
- Karyopharm Therapeutics Inc. (Prot #KCP-330-006 // Prot #KCP-330-006)
Prot #KCP-330-006: A Phase 2, Open-label Study of the Safety and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients with Advanced Squamous Cell Carcinoma of Head and Neck, Lung, or Esophagus
- Nimeiri, Halla S (PD/PI)
Project: Research project